Biotechnology

by Accenture
Mergers and acquisitions in the global chemicals industry have tumbled from their highs of the 2007­-2009 period, jolted by the Great Recession and despite the steady, albeit gradual, recovery in chemicals markets since then, M&A has not returned to those past levels. The reasons for the M&A slowdown are likely due to the uncertainty of global economic health, greater diligence in managing financials (i.e. debt and cash), volatile exchange rates and prices and a digestion of the major acquisitions of the recent past. […] Read more